All updated as on -
The market for food supplements and medications used in IVF in the UAE is anticipated to grow at a 7.8% CAGR from 2023 to 2030, reaching a value of USD 36 billion. The market for dietary supplements and IVF medications in the UAE has expanded as a result of rising healthcare spending demands and increased R&D. Governmental organisations are also approving things.
A sort of assisted reproductive technology known as IVF, often known as "in vitro fertilisation," involves artificially stimulating a woman's reproductive system to produce oocytes. These oocytes are then removed, fertilised in a laboratory, and reinserted into the female uterus. The method of having a child in a lab is known as IVF. IVF is a multi-step process. Ovulation is induced, the ovaries are stimulated, oocytes are harvested, fertilised with sperm, and then delivered to the uterus to implant and develop. The most effective pharmacological regimen and therapeutic intervention are selected following a thorough evaluation before therapy and a precise diagnosis. Ovarian stimulation (LH) is controlled by the gonadotropin-releasing hormone (GnRH) analogues and natural steroid hormone inhibitors clomiphene citrate, recombinant follicle-stimulating hormone (FSH), and luteinizing hormone. They are frequently used by women undergoing IVF to stimulate the production of more eggs in the ovaries, enabling them to become pregnant. The fact that leading competitors and existing market participants are concentrating the majority of their efforts on building bigger and better IVF facilities can be credited to the growth of the UAE IVF drugs and food supplements market. For instance, TVM Capital Healthcare announced on November 14, 2021 that it was selling Bourn Hall Fertility Centre to Mediclinic Middle East, a division of Mediclinic International that operates seven hospitals in the United Arab Emirates. In the MENA region, Bourn Hall Fertility Centre is a centre with expertise in IVF. In December 2018, Mediclinic Middle East had already acquired 30% of the stock. The purpose of this acquisition is to broaden the scope of services provided by in vitro fertilisation (IVF) facilities so they can deliver the greatest medical care and achieve the best outcomes.
Hospital pharmacies, retail pharmacies, and online pharmacies are the three categories into which the UAE IVF medications and food supplements market is divided based on the distribution channel. With a market revenue of $8 billion in 2021, the online pharmacies segment had the biggest market share at 40%. There are increasing online sales of IVF medications and dietary supplements in the nation for a variety of reasons. There are more individuals utilising the internet, more things are available every day of the week, and there are more people using it.
Report Coverage
Global IVF Drugs and Food Supplements research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global IVF Drugs and Food Supplements report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and IVF Drugs and Food Supplements competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key IVF Drugs and Food Supplements market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global IVF Drugs and Food Supplements market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, IVF Drugs and Food Supplements market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Shinelife, Adorefem, LG Chem, Adorshea, Biofield Pharma, Medibyte, Mestra Pharma, and Dr. D Pharma, Abbott, Zydus, Takeda Pharmaceutical Company Limited, Merck KgaA, Ferring B.V.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global IVF Drugs and Food Supplements market based on the below-mentioned segments:
Global IVF Drugs and Food Supplements Market, By Type
Global IVF Drugs and Food Supplements market, By Distribution Channel
Global IVF Drugs and Food Supplements market, Regional Analysis
A sort of assisted reproductive technology known as IVF, often known as "in vitro fertilisation," involves artificially stimulating a woman's reproductive system to produce oocytes. These oocytes are then removed, fertilised in a laboratory, and reinserted into the female uterus. The method of having a child in a lab is known as IVF. IVF is a multi-step process. Ovulation is induced, the ovaries are stimulated, oocytes are harvested, fertilised with sperm, and then delivered to the uterus to implant and develop. The most effective pharmacological regimen and therapeutic intervention are selected following a thorough evaluation before therapy and a precise diagnosis. Ovarian stimulation (LH) is controlled by the gonadotropin-releasing hormone (GnRH) analogues and natural steroid hormone inhibitors clomiphene citrate, recombinant follicle-stimulating hormone (FSH), and luteinizing hormone. They are frequently used by women undergoing IVF to stimulate the production of more eggs in the ovaries, enabling them to become pregnant. The fact that leading competitors and existing market participants are concentrating the majority of their efforts on building bigger and better IVF facilities can be credited to the growth of the UAE IVF drugs and food supplements market. For instance, TVM Capital Healthcare announced on November 14, 2021 that it was selling Bourn Hall Fertility Centre to Mediclinic Middle East, a division of Mediclinic International that operates seven hospitals in the United Arab Emirates. In the MENA region, Bourn Hall Fertility Centre is a centre with expertise in IVF. In December 2018, Mediclinic Middle East had already acquired 30% of the stock. The purpose of this acquisition is to broaden the scope of services provided by in vitro fertilisation (IVF) facilities so they can deliver the greatest medical care and achieve the best outcomes.
Hospital pharmacies, retail pharmacies, and online pharmacies are the three categories into which the UAE IVF medications and food supplements market is divided based on the distribution channel. With a market revenue of $8 billion in 2021, the online pharmacies segment had the biggest market share at 40%. There are increasing online sales of IVF medications and dietary supplements in the nation for a variety of reasons. There are more individuals utilising the internet, more things are available every day of the week, and there are more people using it.
Report Coverage
Global IVF Drugs and Food Supplements research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global IVF Drugs and Food Supplements report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and IVF Drugs and Food Supplements competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key IVF Drugs and Food Supplements market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2020 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2019 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Shinelife, Adorefem, LG Chem, Adorshea, Biofield Pharma, Medibyte, Mestra Pharma, and Dr. D Pharma, Abbott, Zydus, Takeda Pharmaceutical Company Limited, Merck KgaA, Ferring B.V. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of IVF Drugs and Food Supplements Market from 2021 to 2030.
- Market Forecast for IVF Drugs and Food Supplements Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, IVF Drugs and Food Supplements competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on IVF Drugs and Food Supplements
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global IVF Drugs and Food Supplements market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, IVF Drugs and Food Supplements market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Shinelife, Adorefem, LG Chem, Adorshea, Biofield Pharma, Medibyte, Mestra Pharma, and Dr. D Pharma, Abbott, Zydus, Takeda Pharmaceutical Company Limited, Merck KgaA, Ferring B.V.
Primary Target Market
- Market Players of IVF Drugs and Food Supplements
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global IVF Drugs and Food Supplements market based on the below-mentioned segments:
Global IVF Drugs and Food Supplements Market, By Type
- Drugs [ Clomiphene, Injectable Hormones ( Human chorionic gonadotropin (Hcg), Follicle- Stimulating hormone ( FSH), Human menopausal gonadotropin ( HMG), Gonadotropin Releasing Hormone ( GnRH), GnRH agonist, and GonGnRH antagonist)
- Food Supplements
Global IVF Drugs and Food Supplements market, By Distribution Channel
- Hospital pharmacies
- Retail Pharmacies
- Online Pharmacies
Global IVF Drugs and Food Supplements market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive ivf drugs and food supplements market market research and competitor analysis for your business to help you develop more profound insights into the ivf drugs and food supplements market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the ivf drugs and food supplements market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.